{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:56:23Z","timestamp":1790535383133,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12823-6","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:01:08Z","timestamp":1790488868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering hidden protein networks in Huntington\u2019s disease: implications for pathogenesis and therapy"],"prefix":"10.1007","volume":"53","author":[{"given":"Chhavi","family":"Panwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falguni","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4263-002X","authenticated-orcid":false,"given":"Vipin Kumar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"10","key":"12823_CR1","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1002\/acn3.52193","volume":"11","author":"K Yang","year":"2024","unstructured":"Yang K et al (2024) Juvenile-onset Huntington\u2019s disease\u2013Spectrum and evolution of presenting movement disorders. Ann Clin Transl Neurol 11(10):2805\u20132810","journal-title":"Ann Clin Transl Neurol"},{"key":"12823_CR2","unstructured":"Findlay Black H (2025) Characterization of a synonymous DNA variant in the HTT gene and its effect on onset of Huntington disease. University of British Columbia"},{"key":"12823_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/5584_2022_742","volume":"1410","author":"H Kim","year":"2023","unstructured":"Kim H, Gomez-Pastor R (2023) HSF1 and Its Role in Huntington's Disease Pathology. Adv Exp Med Biol 1410:35\u201395","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"12823_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/mds.29427","volume":"38","author":"A Heinzmann","year":"2023","unstructured":"Heinzmann A et al (2023) Huntington\u2019s disease with small CAG repeat expansions. Mov Disord 38(7):1294\u20131306","journal-title":"Mov Disord"},{"issue":"7","key":"12823_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s11055-024-01639-1","volume":"54","author":"RS Kaundal","year":"2024","unstructured":"Kaundal RS, Pandey T, Pandey V (2024) Exploring the thermodynamics of protein aggregation: an insight to Huntington\u2019s disease therapeutics. Neurosci Behav Physiol 54(7):1042\u20131060","journal-title":"Neurosci Behav Physiol"},{"issue":"4","key":"12823_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/biology13040238","volume":"13","author":"J Ojalvo-Pacheco","year":"2024","unstructured":"Ojalvo-Pacheco J et al (2024) Role of TFEB in Huntington\u2019s Disease. Biology 13(4):238","journal-title":"Biology"},{"issue":"1","key":"12823_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10048-025-00801-2","volume":"26","author":"OK Kunwar","year":"2025","unstructured":"Kunwar OK, Singh S (2025) Neuroinflammation and neurodegeneration in Huntington\u2019s disease: genetic hallmarks, role of metals and organophosphates. Neurogenetics 26(1):21","journal-title":"Neurogenetics"},{"issue":"3","key":"12823_CR8","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s11845-022-03043-5","volume":"192","author":"MQ Khan","year":"2023","unstructured":"Khan MQ et al (2023) Computational insights into missense mutations in HTT gene causing Huntington\u2019s disease and its interactome networks. Ir J Med Sci (1971-) 192(3):1435\u20131445","journal-title":"Ir J Med Sci (1971-)"},{"issue":"22","key":"12823_CR9","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.3390\/ijms262210907","volume":"26","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang S, Wang C (2025) Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington\u2019s Disease. Int J Mol Sci 26(22):10907","journal-title":"Int J Mol Sci"},{"issue":"6","key":"12823_CR10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/biomedicines10061432","volume":"10","author":"A Jurcau","year":"2022","unstructured":"Jurcau A (2022) Molecular pathophysiological mechanisms in Huntington\u2019s disease. Biomedicines 10(6):1432","journal-title":"Biomedicines"},{"issue":"1","key":"12823_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10571-025-01604-7","volume":"45","author":"D Mohan Kumar","year":"2025","unstructured":"Mohan Kumar D, Talwar P (2025) Amyloid-\u03b2, tau, and \u03b1-synuclein protein interactomes as therapeutic targets in neurodegenerative diseases. Cell Mol Neurobiol 45(1):84","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"12823_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cels.2022.01.005","volume":"13","author":"TM Greco","year":"2022","unstructured":"Greco TM et al (2022) Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease. Cell Syst 13(4):304\u2013320e5","journal-title":"Cell Syst"},{"key":"12823_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis-an updated review. Mitochondrion 71:83\u201392","journal-title":"Mitochondrion"},{"key":"12823_CR14","doi-asserted-by":"publisher","first-page":"100888","DOI":"10.1016\/j.imu.2022.100888","volume":"30","author":"NI Mahbub","year":"2022","unstructured":"Mahbub NI et al (2022) Identifying molecular signatures and pathways shared between Alzheimer\u2019s and Huntington\u2019s disorders: a bioinformatics and systems biology approach. Inf Med Unlocked 30:100888","journal-title":"Inf Med Unlocked"},{"issue":"10","key":"12823_CR15","doi-asserted-by":"publisher","first-page":"e70053","DOI":"10.1111\/cns.70053","volume":"30","author":"AA Bhat","year":"2024","unstructured":"Bhat AA et al (2024) Therapeutic approaches targeting aging and cellular senescence in Huntington\u2019s disease. CNS Neurosci Ther 30(10):e70053","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"12823_CR16","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.3390\/ijms23105853","volume":"23","author":"A-C Vagiona","year":"2022","unstructured":"Vagiona A-C et al (2022) Analysis of huntington\u2019s disease modifiers using the hyperbolic mapping of the protein interaction network. Int J Mol Sci 23(10):5853","journal-title":"Int J Mol Sci"},{"key":"12823_CR17","first-page":"1","volume":"146","author":"C Selvaraj","year":"2025","unstructured":"Selvaraj C et al (2025) Proteostasis imbalance: Unraveling protein aggregation in neurodegenerative diseases and emerging therapeutic strategies. Adv Protein Chem Struct Biology 146:1\u201334","journal-title":"Adv Protein Chem Struct Biology"},{"key":"12823_CR18","first-page":"297","volume-title":"A Comprehensive Review of the Ubiquitin-Proteasome System in Synapse Remodeling and Neurodegenerative Diseases","author":"M Kumari","year":"2025","unstructured":"Kumari M (2025) A Comprehensive Review of the Ubiquitin-Proteasome System in Synapse Remodeling and Neurodegenerative Diseases. Investigating Molecular Dynamics in Neurodegenerative Disorders, Proteostasis, pp 297\u2013327"},{"key":"12823_CR19","doi-asserted-by":"publisher","first-page":"966019","DOI":"10.3389\/fnins.2022.966019","volume":"16","author":"S Thellung","year":"2022","unstructured":"Thellung S et al (2022) Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets. Front NeuroSci 16:966019","journal-title":"Front NeuroSci"},{"issue":"4","key":"12823_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/1389200223666220321103942","volume":"23","author":"E Srinivasan","year":"2022","unstructured":"Srinivasan E, Ram V, Rajasekaran R (2022) A review on Huntington protein: insight into protein aggregation and therapeutic interventions. Curr Drug Metab 23(4):260\u2013282","journal-title":"Curr Drug Metab"},{"key":"12823_CR21","doi-asserted-by":"crossref","unstructured":"Bisht D, Prakash D (2025) Ameliorative Effects of Heat Shock Proteins in Therapeutic Implications of Neurodegenerative Diseases. In Proteostasis: Investigating Molecular Dynamics in Neurodegenerative Disorders. Springer, pp 353\u2013369","DOI":"10.1007\/978-981-96-6202-9_16"},{"issue":"2","key":"12823_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/ijms23020780","volume":"23","author":"S Maity","year":"2022","unstructured":"Maity S et al (2022) Impact of ER stress and ER-mitochondrial crosstalk in Huntington\u2019s disease. Int J Mol Sci 23(2):780","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12823_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s40478-025-02131-8","volume":"13","author":"MJ Berg","year":"2025","unstructured":"Berg MJ et al (2025) Pathobiology of the autophagy-lysosomal pathway in the Huntington\u2019s disease brain. Acta Neuropathol Commun 13(1):228","journal-title":"Acta Neuropathol Commun"},{"key":"12823_CR24","doi-asserted-by":"crossref","unstructured":"Manoa T, Iwatab A (2022) Autophagy and Huntington\u2019s. Autophagy Dysfunction in Alzheimer\u2019s Disease and Dementia, p 245","DOI":"10.1016\/B978-0-323-89906-2.00001-0"},{"issue":"4","key":"12823_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/neuroglia5040026","volume":"5","author":"D Ghosh","year":"2024","unstructured":"Ghosh D, Kumar A (2024) Harnessing mitophagy for therapeutic advances in aging and chronic neurodegenerative diseases. Neuroglia 5(4):391\u2013409","journal-title":"Neuroglia"},{"key":"12823_CR26","doi-asserted-by":"crossref","unstructured":"Radford R, Wong M, Pountney DL (2023) Neurodegenerative Aspects of Multiple System Atrophy. In Handbook of Neurotoxicity. Springer, pp 1869\u20131892","DOI":"10.1007\/978-3-031-15080-7_110"},{"key":"12823_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/5584_2022_733","volume":"1409","author":"AY Liu","year":"2023","unstructured":"Liu AY, Minetti CA, Remeta DP, Breslauer KJ, Chen KY (2023) HSF1, Aging, and Neurodegeneration. Adv Exp Med Biol 1409:23\u201349","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"12823_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10072-024-07802-3","volume":"46","author":"V Sharma","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG (2025) Mechanistic insights on the role of Nrf-2 signalling in Huntington\u2019s disease. Neurol Sci 46(2):593\u2013604","journal-title":"Neurol Sci"},{"issue":"5","key":"12823_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/01913123.2022.2100951","volume":"46","author":"M Vanisova","year":"2022","unstructured":"Vanisova M et al (2022) Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington\u2019s disease. Ultrastruct Pathol 46(5):462\u2013475","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"12823_CR30","first-page":"2504","volume":"16","author":"S Khan","year":"2024","unstructured":"Khan S et al (2024) Excitotoxicity, oxytosis\/ferroptosis, and neurodegeneration: emerging insights into mitochondrial mechanisms. Aging Disease 16(5):2504","journal-title":"Aging Disease"},{"key":"12823_CR31","doi-asserted-by":"publisher","first-page":"122362","DOI":"10.1016\/j.lfs.2023.122362","volume":"338","author":"MA El-Emam","year":"2024","unstructured":"El-Emam MA et al (2024) Morin suppresses mTORc1\/IRE-1\u03b1\/JNK and IP3R-VDAC-1 pathways: Crucial mechanisms in apoptosis and mitophagy inhibition in experimental Huntington\u2019s disease, supported by in silico molecular docking simulations. Life Sci 338:122362","journal-title":"Life Sci"},{"issue":"3","key":"12823_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/18796397251330144","volume":"14","author":"M Abedrabbo","year":"2025","unstructured":"Abedrabbo M et al (2025) Emerging roles of microglia and neuroinflammation in Huntington\u2019s disease: From pathophysiology to clinical trials. J Huntington\u2019s Disease 14(3):241\u2013257","journal-title":"J Huntington\u2019s Disease"},{"issue":"1","key":"12823_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s10020-024-00917-5","volume":"30","author":"ME Noureldeen","year":"2024","unstructured":"Noureldeen ME et al (2024) Parthenolide ameliorates 3-nitropropionic acid-induced Huntington\u2019s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting. Mol Med 30(1):158","journal-title":"Mol Med"},{"issue":"1","key":"12823_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12974-022-02419-9","volume":"19","author":"K-P Chen","year":"2022","unstructured":"Chen K-P et al (2022) A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington\u2019s disease. J Neuroinflamm 19(1):56","journal-title":"J Neuroinflamm"},{"key":"12823_CR35","doi-asserted-by":"publisher","first-page":"149784","DOI":"10.1016\/j.brainres.2025.149784","volume":"1864","author":"V Sharma","year":"2025","unstructured":"Sharma V et al (2025) Therapeutic modulation of cGAS-STING pathway in neurodegeneration. Brain Res 1864:149784","journal-title":"Brain Res"},{"issue":"6","key":"12823_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3892\/ijmm.2026.5817","volume":"57","author":"X Dai","year":"2026","unstructured":"Dai X et al (2026) Role of aging-related cytokines in neurodegenerative disease. Int J Mol Med 57(6):146","journal-title":"Int J Mol Med"},{"issue":"4","key":"12823_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00702-024-02744-8","volume":"131","author":"KA Jellinger","year":"2024","unstructured":"Jellinger KA (2024) Mild cognitive impairment in Huntington\u2019s disease: challenges and outlooks. J Neural Transm 131(4):289\u2013304","journal-title":"J Neural Transm"},{"issue":"1","key":"12823_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-025-10840-5","volume":"52","author":"A Pal","year":"2025","unstructured":"Pal A et al (2025) Alfalfa (Medicago sativa) and neurodegeneration: mechanistic insights into oxidative stress, inflammation, and neuronal survival pathways. Mol Biol Rep 52(1):1\u201320","journal-title":"Mol Biol Rep"},{"issue":"1","key":"12823_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1073858420972662","volume":"28","author":"C Cepeda","year":"2022","unstructured":"Cepeda C, Levine MS (2022) Synaptic dysfunction in Huntington\u2019s disease: lessons from genetic animal models. Neuroscientist 28(1):20\u201340","journal-title":"Neuroscientist"},{"issue":"1","key":"12823_CR40","doi-asserted-by":"publisher","first-page":"8982","DOI":"10.1038\/s41598-022-13029-z","volume":"12","author":"JM de Souza","year":"2022","unstructured":"de Souza JM et al (2022) mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington\u2019s disease phenotype. Sci Rep 12(1):8982","journal-title":"Sci Rep"},{"issue":"8","key":"12823_CR41","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3390\/biomedicines11082275","volume":"11","author":"A Speidell","year":"2023","unstructured":"Speidell A, Abid NB, Yano H (2023) Brain-derived neurotrophic factor dysregulation as an essential pathological feature in Huntington\u2019s disease: mechanisms and potential therapeutics. Biomedicines 11(8):2275","journal-title":"Biomedicines"},{"key":"12823_CR42","doi-asserted-by":"crossref","unstructured":"Singh AK et al (2026) Therapeutic Potential of HDAC Inhibitors in Neurodegenerative Diseases. In Ubiquitin Proteasome System in CNS Neurodegenerative Diseases. Springer, pp 299\u2013327","DOI":"10.1007\/978-981-95-6099-8_14"},{"issue":"3","key":"12823_CR43","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s10787-024-01477-0","volume":"32","author":"P Temgire","year":"2024","unstructured":"Temgire P, Arthur R, Kumar P (2024) Neuroinflammation and the role of epigenetic-based therapies for Huntington\u2019s disease management: the new paradigm. Inflammopharmacology 32(3):1791\u20131804","journal-title":"Inflammopharmacology"},{"issue":"1","key":"12823_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13578-023-00953-4","volume":"13","author":"D Jiang","year":"2023","unstructured":"Jiang D et al (2023) Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration. Cell Bioscience 13(1):10","journal-title":"Cell Bioscience"},{"issue":"11","key":"12823_CR45","doi-asserted-by":"publisher","first-page":"e70269","DOI":"10.1111\/jnc.70269","volume":"169","author":"R N\u00f3brega-Martins","year":"2025","unstructured":"N\u00f3brega-Martins R et al (2025) RNA granules at the crossroads of synaptic dysfunction and neurodegeneration. J Neurochem 169(11):e70269","journal-title":"J Neurochem"},{"issue":"6","key":"12823_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/genes15060807","volume":"15","author":"M Pengo","year":"2024","unstructured":"Pengo M, Squitieri F (2024) Beyond CAG repeats: the multifaceted role of genetics in Huntington disease. Genes 15(6):807","journal-title":"Genes"},{"key":"12823_CR47","doi-asserted-by":"crossref","unstructured":"Natalia GR et al (2025) Exploring the interaction between nucleotide excision repair pathways and Huntington disease: implications for neurodegeneration and phenotypic overlap. Parkinsonism & Related Disorders, p 108091","DOI":"10.1016\/j.parkreldis.2025.108091"},{"issue":"6","key":"12823_CR48","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41556-024-01414-x","volume":"26","author":"R Aviner","year":"2024","unstructured":"Aviner R et al (2024) Polyglutamine-mediated ribotoxicity disrupts proteostasis and stress responses in Huntington\u2019s disease. Nat Cell Biol 26(6):892\u2013902","journal-title":"Nat Cell Biol"},{"issue":"7","key":"12823_CR49","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/ijms25073845","volume":"25","author":"H Tong","year":"2024","unstructured":"Tong H et al (2024) Huntington\u2019s disease: complex pathogenesis and therapeutic strategies. Int J Mol Sci 25(7):3845","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12823_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12035-025-05510-3","volume":"63","author":"M Hashemi","year":"2026","unstructured":"Hashemi M et al (2026) MicroRNAs and Long Non-Coding RNAs Affect the Mechanisms Involved in Age-Related Neurodegeneration in a Manner Depending on RNA-Binding Proteins. Mol Neurobiol 63(1):343","journal-title":"Mol Neurobiol"},{"issue":"3","key":"12823_CR51","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/antiox12030571","volume":"12","author":"F D\u2019Egidio","year":"2023","unstructured":"D\u2019Egidio F et al (2023) Cell rearrangement and oxidant\/antioxidant imbalance in Huntington\u2019s disease. Antioxidants 12(3):571","journal-title":"Antioxidants"},{"issue":"1","key":"12823_CR52","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12864-024-10534-5","volume":"25","author":"M Liu","year":"2024","unstructured":"Liu M et al (2024) Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington\u2019s disease. BMC Genomics 25(1):633","journal-title":"BMC Genomics"},{"issue":"1","key":"12823_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s12035-026-05967-w","volume":"63","author":"HR Dontiboina","year":"2026","unstructured":"Dontiboina HR et al (2026) 3-Nitropropionic Acid\u2013Induced Huntington\u2019s Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model Gaps, and Future Directions. Mol Neurobiol 63(1):662","journal-title":"Mol Neurobiol"},{"issue":"01","key":"12823_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/nep3.68","volume":"3","author":"SK Saxena","year":"2025","unstructured":"Saxena SK et al (2025) Decoding the role of large heat shock proteins in the progression of neuroinflammation-mediated neurodegenerative disorders. Neuroprotection 3(01):48\u201362","journal-title":"Neuroprotection"},{"issue":"8","key":"12823_CR55","doi-asserted-by":"publisher","first-page":"e70041","DOI":"10.1096\/fba.2025-00093","volume":"7","author":"X Wang","year":"2025","unstructured":"Wang X et al (2025) Unraveling the vicious cycle: oxidative stress and neurotoxicity in neurodegenerative diseases. FASEB BioAdvances 7(8):e70041","journal-title":"FASEB BioAdvances"},{"issue":"1","key":"12823_CR56","doi-asserted-by":"publisher","first-page":"7619255","DOI":"10.1155\/2022\/7619255","volume":"2022","author":"L Liu","year":"2022","unstructured":"Liu L et al (2022) Cross-Talking Pathways of Forkhead Box O1 (FOXO1) Are Involved in the Pathogenesis of Alzheimer\u2019s Disease and Huntington\u2019s Disease. Oxidative Med Cell Longev 2022(1):7619255","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"12823_CR57","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12035-025-05332-3","volume":"63","author":"R Amirian","year":"2026","unstructured":"Amirian R et al (2026) Navigating the Autophagy Maze: ATG and Their Impact on Neurodegenerative Diseases. Mol Neurobiol 63(1):260","journal-title":"Mol Neurobiol"},{"key":"12823_CR58","doi-asserted-by":"crossref","unstructured":"Gouri H, Bararia Y, Malhotra V (2025) The Mitochondrial Interactome in Parkinson\u2019s and Huntington\u2019s Diseases. Nat Cell Sci, 3(3)","DOI":"10.61474\/ncs.2025.00017"},{"issue":"6","key":"12823_CR59","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J et al (2022) Neuroinflammation in Huntington\u2019s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol 20(6):1116\u20131143","journal-title":"Curr Neuropharmacol"},{"key":"12823_CR60","doi-asserted-by":"publisher","first-page":"1456052","DOI":"10.3389\/fnmol.2024.1456052","volume":"17","author":"RM Fisher","year":"2024","unstructured":"Fisher RM, Torrente MP (2024) Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics. Front Mol Neurosci 17:1456052","journal-title":"Front Mol Neurosci"},{"issue":"23","key":"12823_CR61","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.3390\/diagnostics13233592","volume":"13","author":"S Ganesh","year":"2023","unstructured":"Ganesh S et al (2023) Exploring Huntington\u2019s disease diagnosis via artificial intelligence models: a comprehensive review. Diagnostics 13(23):3592","journal-title":"Diagnostics"},{"issue":"1","key":"12823_CR62","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s11033-025-10852-1","volume":"52","author":"F Goel","year":"2025","unstructured":"Goel F et al (2025) Evidence based molecular pathways, available drug targets, pre-clinical animal models and future disease modifying treatments of huntington\u2019s disease. Mol Biol Rep 52(1):754","journal-title":"Mol Biol Rep"},{"key":"12823_CR63","doi-asserted-by":"publisher","first-page":"1526786","DOI":"10.3389\/fimmu.2025.1526786","volume":"16","author":"K-l He","year":"2025","unstructured":"He K-l et al (2025) A new perspective on the regulation of neuroinflammation in intracerebral hemorrhage: mechanisms of NLRP3 inflammasome activation and therapeutic strategies. Front Immunol 16:1526786","journal-title":"Front Immunol"},{"issue":"3","key":"12823_CR64","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/ijms27031592","volume":"27","author":"L Chico","year":"2026","unstructured":"Chico L et al (2026) Nrf2-activating natural compounds in neurodegenerative diseases: targeting oxidative stress and protein aggregation. Int J Mol Sci 27(3):1592","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12823_CR65","doi-asserted-by":"publisher","first-page":"9932218","DOI":"10.1155\/2021\/9932218","volume":"2021","author":"D-D Zhou","year":"2021","unstructured":"Zhou D-D et al (2021) Effects and mechanisms of resveratrol on aging and age-related diseases. Oxidative Med Cell Longev 2021(1):9932218","journal-title":"Oxidative Med Cell Longev"},{"issue":"20","key":"12823_CR66","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.3390\/nu14204383","volume":"14","author":"T Tippairote","year":"2022","unstructured":"Tippairote T et al (2022) Combined supplementation of coenzyme Q10 and other nutrients in specific medical conditions. Nutrients 14(20):4383","journal-title":"Nutrients"},{"issue":"19","key":"12823_CR67","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/cells14191514","volume":"14","author":"PM Gavgani","year":"2025","unstructured":"Gavgani PM, Garc\u00eda-Dom\u00ednguez M (2025) Revolutionizing Huntington\u2019s disease treatment: breakthroughs in AAV-mediated gene therapy. Cells 14(19):1514","journal-title":"Cells"},{"issue":"2","key":"12823_CR68","doi-asserted-by":"publisher","first-page":"e00495","DOI":"10.1016\/j.neurot.2024.e00495","volume":"22","author":"DA Simmons","year":"2025","unstructured":"Simmons DA et al (2025) Small molecule modulation of p75NTR engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington\u2019s disease. Neurotherapeutics 22(2):e00495","journal-title":"Neurotherapeutics"},{"issue":"3","key":"12823_CR69","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40495-024-00356-0","volume":"10","author":"A Sood","year":"2024","unstructured":"Sood A et al (2024) Mitochondria modulating therapeutic approaches in the management of Huntington\u2019s disease. Curr Pharmacol Rep 10(3):207\u2013222","journal-title":"Curr Pharmacol Rep"},{"key":"12823_CR70","doi-asserted-by":"crossref","unstructured":"Sanshita RB et al (2023) Repurposing of Minocycline, a Tetracycline Antibiotic, for Neurodegenerative Disorders. In Drug Repurposing for Emerging Infectious Diseases and Cancer. Springer, pp 615\u2013654","DOI":"10.1007\/978-981-19-5399-6_27"},{"key":"12823_CR71","doi-asserted-by":"crossref","unstructured":"Cisternas-Olmedo M et al (2025) Neuroprotective and gut health benefits of Ugni molinae in preclinical Huntington\u2019s disease models. Exp Neurol, : p. 115406","DOI":"10.1016\/j.expneurol.2025.115406"},{"key":"12823_CR72","doi-asserted-by":"crossref","unstructured":"Fahmy MI et al (2026) Resveratrol alleviates neurological disorders and motor dysfunction in 3-NP induced-Huntington Disease in rats: Role of activating AMPK\/SIRT1\/ULK1 autophagy pathway. Neuropharmacology, 111084","DOI":"10.1016\/j.neuropharm.2026.111084"},{"key":"12823_CR73","doi-asserted-by":"crossref","unstructured":"Moraes MC et al (2026) Metabolic-based therapeutic strategies to treat Huntington\u2019s disease. Neural Regeneration Re:104103","DOI":"10.4103\/NRR.NRR-D-25-01573"},{"issue":"2","key":"12823_CR74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40259-022-00519-9","volume":"36","author":"ME Rook","year":"2022","unstructured":"Rook ME, Southwell AL (2022) Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic: ME Rook. BioDrugs 36(2):105\u2013119","journal-title":"BioDrugs"},{"issue":"1","key":"12823_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10048-026-00887-2","volume":"27","author":"R Kaushal","year":"2026","unstructured":"Kaushal R et al (2026) Gene therapy for huntington\u2019s disease: advances, challenges, and future perspectives. Neurogenetics 27(1):17","journal-title":"Neurogenetics"},{"issue":"14","key":"12823_CR76","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.3390\/ijms23147813","volume":"23","author":"D Vignone","year":"2022","unstructured":"Vignone D et al (2022) Modelling the human blood\u2013brain barrier in Huntington disease. Int J Mol Sci 23(14):7813","journal-title":"Int J Mol Sci"},{"issue":"12","key":"12823_CR77","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.3390\/biomedicines11123331","volume":"11","author":"G Nittari","year":"2023","unstructured":"Nittari G et al (2023) Rodent models of Huntington\u2019s disease: an overview. Biomedicines 11(12):3331","journal-title":"Biomedicines"},{"issue":"1","key":"12823_CR78","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41598-025-85580-4","volume":"15","author":"O Ozisik","year":"2025","unstructured":"Ozisik O et al (2025) A collaborative network analysis for the interpretation of transcriptomics data in Huntington\u2019s disease. Sci Rep 15(1):1412","journal-title":"Sci Rep"},{"issue":"14","key":"12823_CR79","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.2174\/011570159X353727250314065140","volume":"23","author":"P Mittal","year":"2025","unstructured":"Mittal P, Gautam RK, Sharma H, Goyal R, Garima, Kapoor R, Kumar D, Kamal MA, Haque S, Gajula SNR (2025) Neural Networks of Knowledge: Ontologies Pioneering Precision Medicine in Neurodegenerative Diseases. Curr Neuropharmacol 23(14):1878\u20131893","journal-title":"Curr Neuropharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12823-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12823-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12823-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:01:53Z","timestamp":1790532113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12823-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12823"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12823-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"23 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declared the absence of any financial or personal conflicts related to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical trial number: not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1626"}}